日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

More countries pause vaccine roll-out for fear of potential clot risks

By JULIAN SHEA in London | China Daily Global | Updated: 2021-03-17 09:30
Share
Share - WeChat
Vials labelled with partially torn sticker "AstraZeneca COVID-19 Coronavirus Vaccine" are seen in front of a displayed EU flag in this illustration taken March 15, 2021. [Photo/Agencies]

Officials from the United Nations and European Union are to hold talks as the temporary suspension of deployment of the AstraZeneca novel coronavirus vaccine continues to spread across the EU, because of fears that it may be connected to cases of blood clotting.

Its suspension, said Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, or WHO, "does not necessarily mean these events are linked to vaccination, but it's routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place".

At the same time as EU countries are increasingly expressing doubts about the vaccine made by the Anglo-Swedish pharmaceutical company, European Commission President Ursula von der Leyen has announced a deal for what she called the "accelerated delivery" of 10 million doses of the vaccine developed by BioNTech and Pfizer, for the second quarter of the year.

"This will bring the total deliveries of this vaccine to 200 million doses for that quarter," she tweeted. "It will give (EU) Member States room to manoeuvre and possibly fill gaps in deliveries."

Germany, France, Portugal and Spain have become the latest countries to join a growing list of countries that have called a temporary halt to use of the vaccine, despite reassurances from the European Medicines Agency, or EMA, that there is no link between the vaccine and a small number of cases of people who developed blood clots after receiving it.

Germany's Health Minister Jens Spahn said the "precautionary" measure was taken after consultation with national health regulator, the Paul Ehrlich Institute (PEI), adding that "the decision is a professional, not political one" and that any further decision on its use would be made based on new information coming from the EMA.

"After new reports of thrombroses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary," said a statement from the health ministry. "The most important thing for confidence is transparency," Spahn added.

French President Emmanuel Macron also announced a temporary halt to its use on Monday. "The decision that was taken, in accordance with our European policy, is to suspend as a precaution the vaccination with AstraZeneca, hoping to resume it as soon as possible if the opinion is favorable," he explained. Macron made the comments at a Franco-Spanish summit, which took place as Spain too stopped using the vaccine for at least a fortnight.

The WHO said on Monday that its Global Advisory Committee on Vaccine Safety would meet on Tuesday, and has been in close contact with the EMA, which has in turn said it will make an announcement about the AstraZeneca vaccine on Thursday, which it hopes will bring the matter to a conclusion.

"EMA currently remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects," the organization said in a statement.

Better news for AstraZeneca has come from Australia, where the country's chief medical officer, Paul Kelly, says there is no link between the vaccine and blood clots.

However, the only vaccine manufacturer in the country, CSL, has said it is in talks with the Australian government about producing alternatives to the AstraZeneca jab.

"While CSL remains open to discussions about manufacture of alternative COVID-19 vaccines, our resources are fully committed to the manufacture of the AstraZeneca vaccine," the company's chief scientific officer, Andrew Nash, told The Guardian.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 美女扣下面流白浆丝袜 | av大片| 青娱乐手机免费视频 | 久久高清免费视频 | 特黄视频 | 亚洲精品一区二区三区在线观看 | 久久草网站 | 一级做a爰片性色毛片视频图片 | 国产高清中文字幕 | 国产精品va一区二区三区 | 国产一区二区精品在线观看 | 国产福利免费观看 | 色综合久久天天综合网 | 麻豆一区二区99久久久久 | 国产999精品久久久影片官网 | 精品久久不卡 | 91无限资源 | 欧美一区二区在线播放 | 草莓视频69| 在线一级片 | 欧美精品一区二区三区四区 | 亚洲一区二区三区福利在线 | 色综合久久久 | 久草网在线 | 午夜激情视频在线 | 在线高清免费观看视频 | 色www精品视频在线观看 | 草草影院地址 | 国产成人一区二区三区 | 日日夜夜天天 | 一区二区三区四区免费看 | 91久久精品久久国产性色也91 | 成人一级片在线观看 | 亚洲精品午夜国产va久久成人 | 欧美一区二区三区爽大粗免费 | 亚洲xx站 | 成人免费网站www网站高清 | 婷婷综合缴情亚洲五月伊 | 那格格| 亚洲一区二区三区高清 | 青青在线香蕉精品视频免费看 |